Icure Pharmaceutical Incorporation (175250) — Free Cash Flow Generation Index

Latest as of June 2020: 39.07x

Icure Pharmaceutical Incorporation (175250) has a Free Cash Flow Generation Index of 39.07x as of June 2020. Free cash flow of ₩7.64 Billion represents 39% of operating cash flow (₩195.44 Million). See 175250 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

39.07x

Free Cash Flow / Operating CF

Free Cash Flow

₩7.64 Billion

KRW

Operating Cash Flow

₩195.44 Million

KRW

Capital Expenditures

₩7.44 Billion

KRW

Icure Pharmaceutical Incorporation Free Cash Flow Generation Index (2017–2017)

Historical FCF Generation Index trend for Icure Pharmaceutical Incorporation across 1 annual periods. Explore Icure Pharmaceutical Incorporation cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Icure Pharmaceutical Incorporation (2017–2017)

Year-by-year Free Cash Flow Generation Index for Icure Pharmaceutical Incorporation. For the full company profile including market capitalisation, see Icure Pharmaceutical Incorporation market cap and net worth.

Year	FCG Index	Free Cash Flow (KRW)	Operating CF	Capital Expenditures	YoY Change
2017	10.02x	₩11.22 Billion	₩1.12 Billion	₩10.10 Billion	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).